[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4252 Introduced in Senate (IS)]

<DOC>






117th CONGRESS
  2d Session
                                S. 4252

To terminate duties and other restrictions on the importation of infant 
                    formula, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                 May 18 (legislative day, May 17), 2022

   Mr. Paul introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL


 
To terminate duties and other restrictions on the importation of infant 
                    formula, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Freedom to Import Infant Formula Act 
of 2022''.

SEC. 2. TERMINATION OF DUTIES AND OTHER RESTRICTIONS ON IMPORTATION OF 
              INFANT FORMULA.

    (a) Duty-Free Treatment of Infant Formula.--On and after the date 
of the enactment of this Act, infant formula classified under heading 
1901.10 of the Harmonized Tariff Schedule of the United States shall 
enter the United States free of duty and free of quantitative 
limitation.
    (b) Importation of Infant Formula Legal for Sale in Certain 
Countries.--
            (1) In general.--Notwithstanding any other provision of 
        law, with respect to infant formula from a country described in 
        paragraph (2)--
                    (A) U.S. Customs and Border Protection may not 
                seize or otherwise enforce restrictions on the 
                importation of such formula if such formula would meet 
                the legal requirements for sale in that country; and
                    (B) such formula is deemed to be in compliance with 
                the requirements under section 412 of the Federal Food, 
                Drug, and Cosmetic Act (21 U.S.C. 350a).
            (2) Country described.--A country described in this 
        paragraph is any of the following:
                    (A) Australia.
                    (B) Canada.
                    (C) Israel.
                    (D) Japan.
                    (E) New Zealand.
                    (F) The United Kingdom.
                    (G) A member country of the European Union.
                    (H) A member country of the European Economic Area.
    (c) Infant Formula Defined.--In this section, the term ``infant 
formula'' has the meaning given that term in section 201(z) of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(z)).
                                 <all>